Yes we should. Here's an article talking ab
Post# of 148187
(Total Views: 545)
Posted On: 08/16/2020 5:30:43 PM
Re: invisioner #49938
Yes we should.
Quote:
Here's an article talking about the dearth of treatments. Not one mention of leronlimab. Should we comment bomb it? https://www.washingtonpost.com/health/2020/08...ts-wrapper
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼